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Abstract
Background: Radiation is a primary or secondary therapeutic modality for treatment of head and neck cancer. A common
side effect of irradiation to the neck and neck region is xerostomia caused by salivary gland dysfunction. Approximately
40,000 new cases of xerostomia result from radiation treatment in the United States each year. The ensuing salivary gland
hypofunction results in significant morbidity and diminishes the effectiveness of anti-cancer therapies as well as the quality
of life for these patients. Previous studies in a rat model have shown no correlation between induction of apoptosis in the
salivary gland and either the immediate or chronic decrease in salivary function following c-radiation treatment.
Methodology/Principal Finding: A significant level of apoptosis can be detected in the salivary glands of FVB mice
following c-radiation treatment of the head and neck and this apoptosis is suppressed in transgenic mice expressing an
activated mutant of Akt (myr-Akt1). Importantly, this suppression of apoptosis in myr-Akt1 mice preserves salivary function,
as measured by saliva output, three and thirty days after c-radiation treatment. In order to translate these studies into a
preclinal model we found that intravenous injection of IGF1 stimulated activation of endogenous Akt in the salivary glands
in vivo. A single injection of IGF1 prior to exposure to c-radiation diminishes salivary acinar cell apoptosis and completely
preserves salivary gland function three and thirty days following irradiation.
Conclusions/Significance: These studies suggest that apoptosis of salivary acinar cells underlies salivary gland hypofunction
occurringsecondarytoradiationoftheheadandneckregion.TargeteddeliveryofIGF1tothesalivaryglandofpatientsreceiving
head and neck irradiation may be useful in reducing or eliminating xerostomia and restoring quality of life to these patients.
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Introduction
The effects of c-radiation upon the salivary gland have been
known for over ninety years having been first described in the
human in 1911 [1]. Radiation-induced damage to the salivary
glands results in xerostomia (dry mouth), and affected patients have
both compromised quantity and quality of saliva that can affect the
emotional and systemic well-being of these individuals [2]. Such
patients suffer from increased oral infections, difficulty in speaking,
difficulty in swallowing food, and problems with digestion. In the
human, the parotid gland is more radiosensitive when compared to
the submandibular gland [3,4]. Various studies have noted over a
50% reduction in parotid gland function within a few days after
exposure of the head and neck region to low doses of irradiation
[reviewed in [5]]. The high sensitivity of the parotid gland has been
suggested to be due to the predominance of serous cells in this gland
as these epithelial cells appear to be the most radiosensitive [3,4].
While numerous experimental models have been used to study
the effects of irradiation upon the salivary gland, the rat is the most
extensively studied. Prior studies have suggested that damage to
the salivary gland occurs in multiple phases [6,7]. The acute
phases (0–60 days) are characterized by a significant decline in
salivary flow rate to approximately 50% of control, loss of
glandular wet weight and acinar cells, and alterations in water and
protein composition of saliva. In the chronic phases (60–240 days),
cell number and protein secretion remain unchanged from the
acute phase, while salivary flow are approximately 30% of control
values [reviewed in [5]].
While there is an appreciation for the changes that are induced
on the cellular and physiological level, the molecular mechanism
underlying thesechangesarenot understood,andmostinvestigators
have suggested that necrosis is responsible for salivary gland
hypofunction. Apoptosis has been discounted as causative because a
single study in rats has shown that less than 2% of salivary acinar
cells are apoptotic six hours following irradiation of rat salivary
glands with X-rays with doses as high as 25 Gy [8]. These results
seemed at variance with the observed 50% decrease in salivary flow
rate detected by three days after x-irradiation at doses of 15 Gy [8],
and thus these investigators concluded that radiation-induced
apoptosis was not causally related to salivary gland dysfunction.
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apoptosis, we have focused upon the anti-apoptotic protein kinase
Akt which is able to suppress apoptosis in a number of cell systems
[9–11]. Our previous studies have demonstrated that salivary
acinar cells are sensitive to c-radiation-induced apoptosis in
primary cultures in vitro and in vivo [12–14]. We have demonstrated
that activated mutants of Akt1 can suppress apoptosis in vitro in
primary cultures as well as established salivary acinar cell lines
[12,15]. Likewise activation of Akt, mediated by stimulation of
cells with IGF1 and EGF can suppress apoptosis in vitro [12].
Expression of constitutively activated Akt1 in transgenic mice
(myr-Akt1) can reduce apoptosis by 70% following targeted head
and neck c-radiation suggesting that apoptosis may have a larger
role in c-radiation-induced salivary gland dysfunction than
originally reported [14]. We report in this study that reduction
of c-radiation-induced apoptosis correlates with improved salivary
flow rates in mice. Importantly, a single injection of recombinant
IGF1, which stimulates activation of endogenous Akt, completely
prevents loss of saliva production 30 days post-irradiation. This
suggests a model for the development of a clinical approach to
suppress salivary gland dysfunction and thus improve the quality
of life in patients undergoing therapeutic head and neck radiation.
Results
Reduced apoptosis in myr-Akt1 parotid glands following
exposure to ionizing radiation
We have previously described the phenotype of transgenic mice
that express the myr-Akt1 transgene in either the mammary gland
[16], or the salivary gland [14]. In this study, we have evaluated the
extent of apoptosis in the parotid salivary gland following exposure of
the head and neck region of control FVB and myr-Akt1 transgenic
mice to increasing doses of c-radiation. Analysis focused on the
parotid salivary gland due to its high sensitivity to radiation and its
functional importance in stimulated salivary flow. Apoptosis was
quantified using immunohistochemical staining for activated caspase-
3. Twenty-four hours after treatment, a significant (p#0.05) level of
apoptosis is detected in FVB control mice (Figure 1A) exposed to 0.5,
1 and 5 Gy doses of radiation that appears to be dose dependent.
Approximately 2.4% of the parotid salivary cells are positive for
activated caspase-3 following exposure to 0.5 Gy, 13% of the parotid
salivary cellsare positivefor activated caspase-3 following exposureto
1 Gy and 27% are caspase-3 positive following exposure to 5 Gy c-
radiation (Figure 1A). Expression of myr-Akt1 significantly (p#0.05)
reduces the number of caspase-3 positive cells at all doses of radiation
24 hours after treatment; less than 1% of parotid salivary cells are
apoptotic following exposure to 0.5 Gy, approximately 3% of parotid
salivary cells are apoptotic after exposure to 1 Gy and approximately
8% of the parotid cells are positive for active caspase-3 following a
single exposure to 5 Gy c-irradiation (Figure 1A). Greater than 95%
of the caspase-3 positive cells in the parotid gland are salivary acinar
cells with few apoptotic ductal cells.
Because therapeutic doses administered to patients are kept below
2 Gy per exposure, we decided to evaluate apoptosis in the parotid
gland and salivary function following a single low dose of radiation
(1 Gy). The number of apoptotic cells was quantitated at 24 hour
intervals following head and neck irradiation. The highest level of
apoptosis in the irradiated parotid glands is observed at 24 hours post
treatment and decreasing numbers of apoptotic cells are detected at
thesubsequenttimesexamined(Figure1B).Akt significantly (p#0.05)
suppresses the early induction of apoptosis (24 hr) when compared to
FVB mice at the same time point. The level of apoptosis returns to
untreated levels by 48–96 hours and no significant (p#0.05)
differences are observed between FVB and myr-Akt1 mice. This
suggests that Akt diminishes the overall cell death in the tissue rather
than delaying cell death. These data are consistent with numerous
studies that have demonstrated that expression of a constitutively
active mutant of Akt is able to suppresses apoptosis induced by many
different stimuli both in vitro and in vivo [9–11].
Preservation of salivary flow rates 3 days after c-radiation
exposure in myr-Akt1 mice
Radiation-induced suppression of salivary function in the rat
has been previously reported to occur almost immediately after
exposure, reach a minimum at three days, and remain decreased
Figure 1. Reduced apoptosis in myr-Akt1 parotid glands
following exposure to ionizing radiation. In A, four-week old
female FVB and myr-Akt1 mice were exposed to 0.5, 1, or 5 Gy c-
radiation and parotid salivary glands were removed 24 hours post-
irradiation. Tissues were embedded into paraffin and sections were
stained for activated caspase-3. The number of caspase-3 positive cells
is graphed as a percentage of the total number of cells per field of view.
In B, four-week old female FVB and myr-Akt1 mice were exposed to
1G yc-irradiation and parotid salivary glands were removed at 24, 48,
72 and 96 hours. Tissues were processed for activated caspase-3
immunohistochemistry as described in A. Five fields of view were
quantitated for each tissue section and graphed using the averages and
SEM from three mice per group. Significant differences (p#0.05) were
determined using a two sample t-test comparing FVB to myr-Akt1 and
significant differences are marked with an asterisk (*).
doi:10.1371/journal.pone.0004663.g001
Salivary Gland Hypofunction
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between myr-Akt1 transgenic mice and FVB control mice
(Figure 1) stimulated us to ask whether there was a difference in
salivary flow rate between these two strains of mice. A significant
decrease (40–62%) in salivary flow is detected in FVB control mice
at each dose of radiation examined (Figure 2). Interestingly similar
to a previous report using p53 null mice [17], apoptosis in the FVB
mice appears to be dose dependent; however the reductions in
salivary function in response to radiation do not appear to be dose
dependent. In myr-Akt1 transgenic mice, the decrease in salivary
flow rate is less severe (4–47%) with a significant (p#0.05)
improvement in salivary output at the lower doses of radiation (1–
2 Gy). These data clearly indicate that, contrary to previous
conclusions by other investigators, the extent of apoptosis induced
in the salivary glands by head and neck irradiation may be causally
related to salivary gland dysfunction.
IGF1 activates Akt in vivo and preserves salivary flow
rates 3 days after c-radiation exposure
We have previously shown that IGF1 induces activation of Akt
in salivary acinar cells and suppresses apoptosis induced by DNA
damage (etoposide) in vitro [12]. Stimulation of cells with both
IGF1 and EGF produced a synergistic activation of Akt and
suppression of apoptosis [12]. We therefore determined whether
intravenous injections of recombinant IGF1 into the tail vein of
mice would activate endogenous Akt in the parotid salivary gland
similar to a previous study [18]. FVB mice were injected with 1, 5,
10, or 50 mg recombinant IGF1 and the activation of Akt was
examined in the parotid gland five minutes after injection.
Injection of 5 mg IGF1 results in the maximal activation of Akt
as determined by immunoblotting with anti-phospho-Akt (threo-
nine
473) antibody (Figure 3A).
We also determined the kinetics with which Akt was activated
following injection of FVB mice with 5 mg IGF1. Parotid glands were
removed at 5, 10, and 30 minutes post injection, tissue lysates
prepared, and the activation of Akt examined by immunoblotting
with anti-phospho-Akt (threonine
473) antibody (Figure 3B). Maximal
activation of Akt in the parotid gland is detected five minutes after
injection of IGF1, and the amount of phosphorylated Akt declines
after this time. However, phosphorylated Akt could still be detected
thirty minutes following administration of IGF1, and may remain
activated for up to four hours post-injection (data not shown).
To determine whether acute administration of mice with IGF1
could suppress radiation-induced salivary gland hypofunction, FVB
mice were anesthetized with avertin, injected with 5 mg IGF1, and
immediately exposed to 1 Gy radiation. Parotid salivary glands
were removed 24 hours later to quantitate the level of apoptosis
using immunohistochemistry for activated caspase-3 (Figure 3C).
Approximately 4% of the parotid salivary cells areapoptotic in mice
receiving IGF1 prior to irradiation which is significantly (p#0.05)
lower than the 13% observed in irradiated FVB. The level of
radiation-induced apoptosis in the IGF1 injected is not significantly
different than the myr-Akt1 mice (3%).
We also evaluated salivary flow rates three days after exposure
to c-radiation. Injection of mice with 5 mg IGF1 alone had no
effect upon the salivary flow rate three days following injection of
the mice (Figure 3D). Following radiation, there is a 40% decrease
in the salivary flow rate compared to unirradiated control mice
(Figure 3D), which is statistically different (p#0.05). Injection of
mice with a single dose of 5 mg recombinant IGF1 completely
suppresses the radiation-induced reduction in salivary flow rate at
this early time point (Figure 3D).
Preservation of salivary flow rates 30 days after c-
radiation exposure by myr-Akt1 or injection with IGF1
One hallmark of radiation-induced salivary gland dysfunction is
that the effect is chronic and there is no recovery in the production
of saliva over time [7]. Therefore we re-evaluated salivary flow
rates in irradiated FVB, myr-Akt1 transgenic and IGF1 pretreated
mice 30 days post c-radiation to determine if the trends observed
three days following irradiation would be retained over time
(Figure 4). There was a slight increase in salivary flow rates in all
unirradiated at day 30 when compared to the flow rates
determined in unirradiated mice on day 3. The flow rate in the
unirradiated myr-Akt1 transgenic mice is higher than the
unirradiated FVB control mice at the thirty day time point, and
this difference is significant (Treatment groups with the same
letters are not significantly different from each other). There is no
statistical difference in the salivary flow rate between unirradiated
FVB control mice and mice injected with IGF1 at the thirty day
time point. There is a 60% decrease in the salivary flow rate in
irradiated FVB mice compared to control mice at the thirty day
time point. In irradiated myr-Akt1 mice, there is a 16% decrease
in salivary flow when compared to FVB untreated controls that is
not significantly different; however it is significantly lower than
unirradiated myr-Akt1. Remarkably, FVB mice injected with a
single dose of IGF1 prior to c-radiation demonstrate no decrease
in salivary flow rate 30 days after irradiation compared to control
mice (FVB or IGF1 injected).
Histologicalanalysisofthesalivaryglandsfromthedifferentgroups
of mice thirty days post treatment (control, irradiated, IGF-1 treated
but unirradiated, and IGF-1 treated and irradiated) were conducted
(Figure 5). Consistent with previous observations in irradiated rats
[19] only minimal or mild focal fibrosis was observed in the
submandibular glands of irradiated mice; a rare large area of fibrosis,
which is not typical of what is generally observed, is shown in
Figure 5D. The extent of fibrosis did not appear to be significantly
different between mice pretreated with IGF-1 prior to irradiation
Figure 2. Preservation of salivary flow rates 3 days after single
c-radiation exposure in myr-Akt1 mice. Four-week old female FVB
and myr-Akt1 mice were exposed to 1, 2, or 5 Gy c-radiation. Three days
after irradiation total saliva was collected (over a five minute period)
following carbachol injection. Statistical analysis was performed using
Student’s t-test in Microsoft Excel. Results shown are from ten mice per
group in the 1 and 2 Gy doses and four mice per group in the 5 Gy
dose. Graphs represent averages and SEM from all mice. Significant
differences (p#0.05) were determined using a two sample t-test
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either the sublingual or parotid glands (compare5B versus 5E and 5C
versus 5F). Pretreatment of mice with IGF-1 did result in some
increase in the large vacuoles in acinar cells in each of the salivary
glands(Figure5G,H,andI).Thesevacuolesarenotprominentinthe
submandibular gland, although they are present in each type of
salivary gland examined (Figure 5G–I). We do not understand the
mechanism that underlies the ability of IGF1 to induce the
appearance of these vacuoles in salivary acinar cells; however, they
have no effect upon production of saliva in the unirradiated mice
(Figure 4D and E).
Discussion
These data indicate that irradiation of FVB mice results in a
significant induction of apoptosis and salivary gland dysfunction
Figure 3. IGF1 activates Akt in vivo and preserves salivary flow rates 3 days after single c-radiation exposure. In A, FVB mice received
an injection of 1, 5, 10, or 50 mg recombinant IGF1. Tissue lysates were collected for immunoblotting five minutes after injection and membranes
were probed for activation of Akt using a phosphorylation specific antibody. Results shown are representative of three independent experiments. In
B, FVB mice received an injection of 5 mg recombinant IGF1 and tissue lysates were collected for immunoblotting 0, 5, 10 or 30 minutes after
injection. Membranes were probed for activated Akt as described in A. Membranes were stripped and re-probed with a total antibody against ERK1/2
as a loading control in both A and B. Results shown are representative of three independent experiments. In C, four-week old female FVB mice were
injected with 5 mg recombinant IGF1 immediately prior to treatment with 1 Gy c-radiation. Salivary glands were removed 24 hours post-irradiation
and stained for activated caspase-3 as described in Figure 1A. Graph represents averages and SEM from at least three mice/treatment. (*) indicates
significant difference (p#0.05) from untreated FVB and (#) indicates significance between 1 Gy FVB and 1 Gy IGF1 or 1 Gy myr-Akt1. In D, four-week
old female mice were injected with 5 mg recombinant IGF1 and treated with radiation as described in C. Total saliva was collected following
carbachol injection 3 days after radiation exposure as described in Figure 2. Statistical analysis was performed using Student’s t-test in Microsoft
Excel. Results shown are from ten irradiated FVB mice and eight IGF1 plus irradiation mice and graphed using the averages and SEM from all mice.
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30 days. Expression of activated myr-Akt1, or pretreatment of mice
with recombinant IGF1, which activates Akt, significantly decreases
the number of apoptotic cells, and significantly suppresses radiation-
induced salivary gland dysfunction. We note that there is a significant
difference in the extent of protection offered by expression of
activated Akt versus that afforded by injection of IGF1 with the latter
providing significantly greater protection. IGF1 is able to activate a
broader spectrum of signaling pathways, including the MAP kinase
pathway, and its greater protection may reflect its ability to both
suppress apoptosis as well as induce proliferation of cells. We suggest
that this difference may account for the greater protection from
irradiation-induced salivary hypofunction offered by IGF1. Further-
more, our results indicate that means to suppress apoptosis in salivary
epithelial cells could prevent inadvertent salivary gland dysfunction
occurring secondary to head and neck irradiation.
In this study we have focused primarily upon the parotid gland.
The submandibular glands contribute approximately two-thirds of
unstimulated saliva volume, whereas parotid glands contribute the
majority of stimulated saliva volume[20,21]. Furthermore
Humphries et al have shown that the extent of irradiation induced
apoptosis is ten-fold lower in the submandibular gland compared
to the parotid gland [22]. For these reason we feel that focusing
our analysis upon the parotid gland is justified.
In recent years, a significant amount of attention has been focused
upon understanding the molecular changes underlying the adverse
effects of therapeutic radiation which negatively impact a patient’s
quality of life as a means for developing useful therapeutic
interventions. Recent studies have suggested that gastrointestinal
syndrome induced by whole body irradiation may result from
radiation-inducedapoptosisofendothelialcells[23].Thisobservation
is contrary to previous hypotheses that gastrointestinal syndrome was
caused by the failure of stem cells within the intestinal crypt to
proliferate and reconstitute the crypt-villus unit. The ability of a
peptide agonist to Toll-like receptor 5 (CBLB502) to preserving
endothelial function in the gastrointestinal tract and prevent
gastrointestinal syndrome has provided confirmatory evidence that
endothelial cells likely represent one important target underlying
gastrointestinal syndrome resulting from whole body irradiation [24].
Although this study reported that CBLB502 did not affect tumor
clearance [24], it is important to note that tumor response to
radiation is also influenced by endothelial apoptosis [25]. These
results indicate the clinical importance of preventing radiation-
induced death of off-target cells in the treatment of cancer patients.
The situation in the salivary gland is somewhat analogous in
that salivary gland hypofunction could result from loss of tissue
stem cells that are capable of repopulating the damaged cells,
damage to secretory acinar epithelial cells, loss of endothelial cells,
or loss of nerve cells required for induction of secretion. Of these
four possibilities, it does not appear that radiation induces changes
to the blood supply [26,27], or the innervation of the salivary
gland [28], although it is possible that a reexamination of these
points using recently generated reagents or techniques could alter
this conclusion. Our results suggest that apoptosis of epithelial cells
may be important in radiation-induced salivary gland hypofunc-
tion and the resulting diminished quality of life for head and neck
cancer patients. Our results also indicate that IGF1 can be used to
prevent salivary epithelial cell apoptosis and loss of glandular
function, which represents a significant difference from studies on
the role of endothelial cell apoptosis in gastrointestinal syndrome.
The tumor suppressor gene p53 has also been shown to be
involved in the radiosensitivity of many tissues [29], and loss of
p53 function represents an important step in tumor progression.
Transgenic mice expressing an inducible form of p53 have been
used to evaluate radiation-induced lymphoma and these studies
concluded that delaying p53 expression until after the apoptotic
response had no effect on eventual tumors caused by radiation
damage [30]. These results indicate that the role of p53 in
apoptosis and tumor suppression are separate functions of p53
[30]. We have previously demonstrated that MDM2 is a critical
target of Akt in the suppression of DNA damage-induced
apoptosis in salivary acinar cells [14]. We observed the Akt-
dependent phosphorylation of MDM2 in the salivary glands of
myr-Akt1 transgenic mice which resulted in complete absence of
p53 from these glands, as well as a significant decrease in two other
p53 family members, p63 and p73[14]. The loss of p53 also
resulted in the decreased expression of p53 target genes such a
p21
WAF1 [14]. These results suggest that the p53 pathway is
critical in regulating the radiosensitivity of the salivary glands[14].
Recently it has been reported that expression of p53 is required for
the acute and chronic loss of salivary function following irradiation
[17]. Temporary suppression of radiation-induced apoptosis of
salivary acinar cells could prevent inadvertent salivary gland
dysfunction occurring secondary to head and neck irradiation
without predisposing the salivary glands to eventual tumorigenesis.
Clearly our work highlights a first step in an effort to improve
the treatment of head and neck cancer patients by preventing the
initial loss of salivary function. Identification of the pathways
mediating the IGF1-Akt preservation of salivary function will
allow specific targeting to the salivary glands without modifying
tumor therapies. Current efforts are directed towards building a
preclinical model to evaluate the effectiveness of this approach.
Methods
Mice
Myr-Akt1 transgenic mice were generated using standard
techniques as described previously by the Transgenic Mouse Core
Figure 4. Preservation of salivary flow rates 30 days after
single c-radiation exposure by myr-Akt1 or injection with IGF1.
Four-week old female FVB, myr-Akt1 and FVB mice injected with 5 mg
recombinant IGF1 were exposed to 1 Gy c-radiation. IGF1 injections
were performed immediately prior to radiation exposure as described in
Figure 3. Thirty days after exposure to c-radiation total saliva was
collected following carbachol injection as described in Figure 2.
Statistical analysis was performed using multiple comparison testing
in the SAS system. Results shown are from ten irradiated FVB mice, ten
irradiated myr-Akt1 mice and eight IGF1 plus irradiation mice and
graphed using the averages and SEM from all mice. Treatment groups
with the same letters are not significantly different from each other.
doi:10.1371/journal.pone.0004663.g004
Salivary Gland Hypofunction
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DNA was extracted and transgenic mice were identified using
PCR as previously described [16]. Non-transgenic littermates were
used as controls in all experiments. Animals were maintained and
treated in accordance with protocols approved by the University of
Colorado Health Sciences Center Laboratory Animal Care and
Use Committee.
c-radiation treatment
For in vivo experiments, four-week old female FVB and myr-
Akt1 transgenic mice were anesthetized with avertin (0.4–0.6 mg/
gm, IP) and the head and neck region was exposed to ionizing
radiation using a RS 2000 Biological Irradiator [22]. The rest of the
body was shielded with ,6 mm lead foil and sheets to avoid
systemic effects of c-irradiation. Mice completely shielded with lead
exhibitednoadverseeffectsofradiationsuggestingthattheshielding
used was sufficient to prevent systemic damage. For IGF1 injections
(GroPrep, Adelaide, Australia), mice were anesthetized with avertin
and tails were warmed in water to allow dilation of blood vessels.
Mice were injected with a total volume of 100 ml of IGF1 diluted in
sterile PBS and immediately placed into the radiation chamber.
Histology
Submandibular, sublingual, and parotid salivary gland tissues were
fixed in 10% neutral buffered formalin, and then embedded in
paraffin. Tissue sections were cut at 4 mm and processed for standard
staining with hematoxylin and eosin by the Histology Service of the
Department of Pathology at the University of Colorado School of
Medicine. Tissue sections were observed by standard light micros-
copy and photomicrographs were taken with an Olympus BX51
microscope with Spot Diagnostic imaging software.
Activated caspase-3 staining
Salivary glands were removed at various time points post-
irradiation, fixed in 10% neutral buffered formalin, and then
embedded in paraffin. Slides were stained for activated caspase-3
(Cell Signaling #9661; Beverly, MA) as previously described
[14,22]. Cell counts were performed on parotid gland sections
from a minimum of five fields of view per slide from three mice per
treatment (total cells counted ranged from 1800–2500 per mouse).
Saliva collection
Mice were injected intraperitoneally with 0.25 mg carbachol
per kg body weight [31]. Saliva was collected immediately
following injection for five min and chilled on ice as previously
described [14].
Statistics
Statistical evaluation for multiple comparisons (Figure 4) was
performed in SAS using general linear means and the least squares
means for effect to control for Type I errors. All other statistical
calculations for Figures 1, 2 and 3 were performed using a two sample
t-test in Microsoft Excel to compare FVB vs. myr-Akt1 or IGF1.
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Figure 5. Histological analysis of salivary glands from normal and irradiated salivary glands from untreated and IGF1-treated mice.
A) Normal submandibular salivary gland showing basic structure of acini (arrows) and ducts (asterisk). B) Normal sublingual salivary gland. C) Normal
parotid gland. D) Submandibular salivary gland thirty days following exposure to 5 Gy radiation. Note area of focal fibrosis and associated
inflammatory cells (asterisk). E) Sublingual salivary gland after thirty days following exposure to 5 Gy radiation. No significant morphological change
is seen. F) Parotid salivary gland after exposure to radiation. No Significant morphological change is seen. G) Submandibular gland thirty days
following injection with 5 ug IGF1. Note the prominent vacuolization of the glandular acini (Arrows). H) Sublingual gland thirty days following
injection with 5 ug IGF1 introduction. Note the prominent vacuolization of the glandular acini (Arrows). I) Parotid gland thirty days following injection
with 5 ug IGF1. Note the mildly increased vacuolization of the glandular acini, although less than that observed in either the submandibular or
sublingual salivary glands (Arrows). J) Submandibular gland thirty days following injection with 5 ug IGF1 immediately prior exposure to 5 Gy
radiation. The left part of the photograph (*) shows atrophy of the acini with mild chronic inflammation. The right side of the picture shows increased
vacuolization in the viable acini (arrows). K) Sublingual gland thirty days following injection with 5 ug IGF1 immediately prior to exposure to 5 Gy
radiation. Increased vacuolization is noted, however, no significant atrophy is seen. L) Parotid gland thirty days following injection with 5 ug IGF1
immediately prior to exposure to 5 Gy radiation. Note the mildly increased vacuolization with no significant atrophy. For Panels A–C, the
magnification is 406, while the magnification D–L is 206.
doi:10.1371/journal.pone.0004663.g005
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